Scotia Capital’s Arrowhead Research ARWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,482
Closed -$231K 921
2025
Q4
$231K Buy
+3,482
New +$171K ﹤0.01% 815
2025
Q3
Sell
-11,795
Closed -$186K 908
2025
Q2
$186K Buy
+11,795
New +$169K ﹤0.01% 809
2022
Q2
Sell
-6,849
Closed -$315K 816
2022
Q1
$315K Buy
6,849
+1,399
+26% +$69.3K ﹤0.01% 718
2021
Q4
$361K Sell
5,450
-193
-3% -$13.3K ﹤0.01% 701
2021
Q3
$352K Buy
5,643
+1,283
+29% +$83.1K ﹤0.01% 685
2021
Q2
$361K Buy
+4,360
New +$325K ﹤0.01% 690

Other funds holding ARWR

Scotia Capital's ARWR Position: Q1 2026 in Review

Scotia Capital sold out of Arrowhead Research (ARWR) in Q1 2026, closing a stake of 3,482 shares — an estimated $231K sold.

Scotia Capital first reported a position in ARWR in Q2 2021 and held it in 6 quarters. The position peaked at $361K in Q4 2021. 436 funds tracked by Wall St. Rank hold ARWR as of Q1 2026.

  • Scotia Capital reported no remaining Arrowhead Research position as of Q1 2026 after selling out during the quarter.
  • Scotia Capital sold 3,482 Arrowhead Research shares in Q1 2026, an estimated $231K.
  • Scotia Capital first reported a position in Arrowhead Research in Q2 2021 and held it in 6 quarters.
  • Scotia Capital's Arrowhead Research position peaked at $361K in Q4 2021.
  • 436 funds tracked by Wall St. Rank held Arrowhead Research as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.